Novartis (NYSE:NVS), a Swiss biopharma, invested $1 billion into an R&D center in Shanghai that will complement its other two major R&D hubs - one in its Basel home and the other in Cambridge, Massachusetts. Originally announced in 2009, the facility will ...
-
-
Recent Updates
- MATRADE and HKTVmall Launch Hong Kong Campaign for Malaysian Brands
- China Auto Exports Jump as Weak Domestic Demand Pressures Carmakers
- Nvidia Rout Deepens as China Chip Allegations Put Jensen Huang Under Scrutiny
- China Trade Surplus Exposes Strains Beneath Its Export Boom
- China Spy Allegations Put Alice Huang and Nvidia Ties under Scrutiny
- Alice Huang China Spy Allegations Put Nvidia Ties Under Scrutiny
- China Auto Exports Accelerate as Domestic Car Demand Stumbles
- China Auto Exports Accelerate as Domestic Car Demand Stumbles
- China-Market Brief: Univest Securities Completes $1.2 Million Offering for Nasdaq-Listed JIADE
- Atlas Copco and Ansteel Deepen China Steel Partnership at Import Expo
Blogroll